1-20 of 55
Authors: James A Karlowsky
Save search
Sort by
Journal Article

Comparing serotype coverage of pneumococcal vaccines with PCV21 (V116), a new 21-valent conjugate pneumococcal vaccine, and the epidemiology of its eight unique Streptococcus pneumoniae serotypes (15A, 15C, 16F, 23A, 23B, 24F, 31 and 35B) causing invasive pneumococcal disease in adult patients in Canada: SAVE study, 2018–21 Open Access

PDF
John J Schellenberg and others
Journal of Antimicrobial Chemotherapy, Volume 80, Issue 5, May 2025, Pages 1377–1385, https://doi.org/10.1093/jac/dkaf085
Published: 25 March 2025
Journal Article

Cefepime–taniborbactam activity against antimicrobial-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa: GEARS global surveillance programme 2018–22 Open Access

PDF
James A Karlowsky and others
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 12, December 2024, Pages 3116–3131, https://doi.org/10.1093/jac/dkae329
Published: 17 September 2024
Journal Article

Phenotypic and molecular characterization of Streptococcus pneumoniae serotype 3 isolates from blood and respiratory samples in Canada: CANWARD 2007–21 Open Access

PDF
John J Schellenberg and others
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 10, October 2024, Pages 2653–2661, https://doi.org/10.1093/jac/dkae272
Published: 02 August 2024
Journal Article

Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011–2020 Free

PDF
Morgan A Alford and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue Supplement_1, May 2023, Pages i8–i16, https://doi.org/10.1093/jac/dkad065
Published: 03 May 2023
Journal Article

Analysis of MDR in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011–2020 Free

PDF
Heather J Adam and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue Supplement_1, May 2023, Pages i17–i25, https://doi.org/10.1093/jac/dkad066
Published: 03 May 2023
Journal Article

Genomic investigation of the most common Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011–2020 Free

PDF
Alyssa R Golden and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue Supplement_1, May 2023, Pages i26–i36, https://doi.org/10.1093/jac/dkad067
Published: 03 May 2023
Journal Article

Comparison of PCV10, PCV13, PCV15, PCV20 and PPSV23 vaccine coverage of invasive Streptococcus pneumoniae isolate serotypes in Canada: the SAVE study, 2011–20 Free

PDF
John J Schellenberg and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue Supplement_1, May 2023, Pages i37–i47, https://doi.org/10.1093/jac/dkad068
Published: 03 May 2023
Journal Article

In vitro activity of sulopenem against 1880 bacterial pathogens isolated from Canadian patients with urinary tract infections (CANWARD, 2014–21) Free

PDF
Andrew J Walkty and others
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 12, December 2022, Pages 3414–3420, https://doi.org/10.1093/jac/dkac333
Published: 30 September 2022
Journal Article

In vitro activity of fosfomycin against bacterial pathogens isolated from urine specimens in Canada from 2007 to 2020: CANWARD surveillance study Free

PDF
James A Karlowsky and others
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 11, November 2022, Pages 3035–3038, https://doi.org/10.1093/jac/dkac275
Published: 16 August 2022
Journal Article

PCV-15 and PPSV-23 coverage of invasive and respiratory tract Streptococcus pneumoniae, including MDR and XDR isolates: CANWARD 2007–20 Free

PDF
Alyssa R. Golden and others
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 5, May 2022, Pages 1444–1451, https://doi.org/10.1093/jac/dkac034
Published: 10 February 2022
Journal Article

Comparison of phenotypic antimicrobial susceptibility testing results and WGS-derived genotypic resistance profiles for a cohort of ESBL-producing Escherichia coli collected from Canadian hospitals: CANWARD 2007–18 Free

PDF
Alyssa R Golden and others
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 11, November 2021, Pages 2825–2832, https://doi.org/10.1093/jac/dkab268
Published: 11 August 2021
Journal Article

ESBL-positive Escherichia coli and Klebsiella pneumoniae isolates from across Canada: CANWARD surveillance study, 2007–18 Free

PDF
James A Karlowsky and others
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 11, November 2021, Pages 2815–2824, https://doi.org/10.1093/jac/dkab269
Published: 11 August 2021
Journal Article
EDITOR'S CHOICE

In vitro activity and resistance rates of topical antimicrobials fusidic acid, mupirocin and ozenoxacin against skin and soft tissue infection pathogens obtained across Canada (CANWARD 2007–18) Free

PDF
George G Zhanel and others
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 7, July 2021, Pages 1808–1814, https://doi.org/10.1093/jac/dkab098
Published: 01 April 2021
Journal Article

Antimicrobial susceptibility of Clostridioides difficile isolated from diarrhoeal stool specimens of Canadian patients: summary of results from the Canadian Clostridioides difficile (CAN-DIFF) surveillance study from 2013 to 2017 Free

PDF
James A Karlowsky and others
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 7, July 2020, Pages 1824–1832, https://doi.org/10.1093/jac/dkaa118
Published: 15 April 2020
Journal Article

Dramatic rise in the proportion of ESBL-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates identified in Canadian hospital laboratories from 2007 to 2016 Free

PDF
Andrew J Denisuik and others
Journal of Antimicrobial Chemotherapy, Volume 74, Issue Supplement_4, August 2019, Pages iv64–iv71, https://doi.org/10.1093/jac/dkz289
Published: 23 August 2019
Journal Article

Characterization of MRSA in Canada from 2007 to 2016 Free

PDF
Kimberly A Nichol and others
Journal of Antimicrobial Chemotherapy, Volume 74, Issue Supplement_4, August 2019, Pages iv55–iv63, https://doi.org/10.1093/jac/dkz288
Published: 23 August 2019
Journal Article

Species distribution and antifungal susceptibility of invasive Candida isolates from Canadian hospitals: results of the CANWARD 2011–16 study Free

PDF
Jeff Fuller and others
Journal of Antimicrobial Chemotherapy, Volume 74, Issue Supplement_4, August 2019, Pages iv48–iv54, https://doi.org/10.1093/jac/dkz287
Published: 23 August 2019
Journal Article

Trends in antimicrobial resistance over 10 years among key bacterial pathogens from Canadian hospitals: results of the CANWARD study 2007–16 Free

PDF
Philippe R S Lagacé-Wiens and others
Journal of Antimicrobial Chemotherapy, Volume 74, Issue Supplement_4, August 2019, Pages iv22–iv31, https://doi.org/10.1093/jac/dkz284
Published: 23 August 2019
Journal Article

42936 pathogens from Canadian hospitals: 10 years of results (2007–16) from the CANWARD surveillance study Free

PDF
George G Zhanel and others
Journal of Antimicrobial Chemotherapy, Volume 74, Issue Supplement_4, August 2019, Pages iv5–iv21, https://doi.org/10.1093/jac/dkz283
Published: 23 August 2019
Journal Article

Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007–16 study Free

PDF
Melissa G McCracken and others
Journal of Antimicrobial Chemotherapy, Volume 74, Issue Supplement_4, August 2019, Pages iv32–iv38, https://doi.org/10.1093/jac/dkz285
Published: 23 August 2019